Pear Therapeutics- Warrants (01/12/2026) Profit Margin

The latest profit margin for PEARW is 195.19% as of December 2022. That compares with -2220.12% in the prior-year period — up 108.8% year over year. That is above the sector sector average of 19.61%. Investors often review this figure alongside Pear Therapeutics- Warrants (01/12/2026)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, PEARW's profit margin moved from -2220.12% to 195.19% — a 108.8% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Pear Therapeutics- Warrants (01/12/2026)'s valuation or profitability profile.

Against its sector companies, PEARW currently prints 195.19% for profit margin, while the sector average sits near 19.61%. That is roughly 895.5% above the sector mean. Large gaps often invite a closer look at Pear Therapeutics- Warrants (01/12/2026)'s growth, margins, and balance sheet.

Profit Margin shows how effectively Pear Therapeutics- Warrants (01/12/2026) converts resources into returns. At 195.19%, PEARW may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -2220.12% in the prior-year period — up 108.8% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting PEARW's profit margin (195.19%), review year-over-year change from -2220.12%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.